Format

Send to

Choose Destination
Nat Rev Drug Discov. 2009 Mar;8(3):235-53. doi: 10.1038/nrd2792.

The FGF family: biology, pathophysiology and therapy.

Author information

1
Department of Pharmacology, New York University School of Medicine, New York, New York 10016, USA. Andrew.Beenken@med.nyu.edu

Abstract

The family of fibroblast growth factors (FGFs) regulates a plethora of developmental processes, including brain patterning, branching morphogenesis and limb development. Several mitogenic, cytoprotective and angiogenic therapeutic applications of FGFs are already being explored, and the recent discovery of the crucial roles of the endocrine-acting FGF19 subfamily in bile acid, glucose and phosphate homeostasis has sparked renewed interest in the pharmacological potential of this family. This Review discusses traditional applications of recombinant FGFs and small-molecule FGF receptor kinase inhibitors in the treatment of cancer and cardiovascular disease and their emerging potential in the treatment of metabolic syndrome and hypophosphataemic diseases.

PMID:
19247306
PMCID:
PMC3684054
DOI:
10.1038/nrd2792
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center